-
Govt may set up ‘Mission COVID Suraksha’ with Rs 3000 crore corpus
expresspharma
August 26, 2020
The initiative will work towards fast-tracking development and manufacture of COVID-19 vaccines in the country.
-
Catalent and AstraZeneca Enter Vaccine Manufacturing Deal
contractpharma
August 25, 2020
Catalent Inc. will provide drug substance manufacturing to AstraZeneca for the University of Oxford’s adenovirus vector-based COVID-19 vaccine, AZD1222, at Catalent’s commercial gene therapy manufacturing facility located in Harmans, Maryland.
-
Novavax commences Phase 2 clinical trial of COVID-19 vaccine candidate
expresspharma
August 25, 2020
Trial to enroll up to 1,500 volunteers in the US and Australia, with approximately 50 per cent between 60 and 84 years of age.
-
CureVac concludes talks with EC for Covid-19 vaccine supply
pharmaceutical-technology
August 24, 2020
German biopharmaceutical firm CureVac has concluded exploratory discussions with the European Commission (EC) on an advanced purchase agreement (APA) for the company’s mRNA-based Covid-19 vaccine candidate.
-
40 per cent participants enrolled for COVID-19 vaccine trial: Moderna
expresspharma
August 24, 2020
Moderna began the study of its vaccine candidate, mRNA-1273, in July and expects to complete enrollment in September.
-
Roll-out plan of Sputnik-V prompts worries about virus mutation
expresspharma
August 24, 2020
Viruses are known for their ability to mutate all the time - and often this has little or no impact on the risk posed to people.
-
Bharat Biotech gets green signal from CDSCO to test COVAXIN via skin
expresspharma
August 24, 2020
As per reports, Bharat Biotech has got an approval from the Drug Controller General of India (DCGI) to conduct a separate clinical trial through which it will test administering their Covid-19 vaccine ‘Covaxin’ through the skin.
-
Panacea Biotec terminates MoU with Refana for COVID-19 vaccine
expresspharma
August 24, 2020
The company informed that the termination is due to delays in project timelines and difficulty in moving ahead with the joint venture.
-
China gives emergency authorisation for COVID-19 vaccines: Official
expresspharma
August 24, 2020
It has been previously reported that employees of state-owned enterprises preparing to go abroad and frontline medics have been offered two choices of domestic inactivated vaccine candidates developed by Sinopharm for urgent use.
-
Intravacc and Celonic to Develop and Produce a Novel COVID-19 Vaccine
b3cnewswire
August 22, 2020
In the beginning of March this year Intravacc started working on the development of four candidate coronavirus vaccines based on three proprietary technologies: Vero cell, OMV and iBoost.